Fomat Medical Research
Oxnard, California 93030
6 studies enrolling now · 16 studies all time
What they study most
Advanced MTAP-null Solid Tumors, Advanced Solid Tumor, Breast Cancer, COVID-19, COVID-19 Disease, COVID-19 SARS-CoV-2 Infection, Cardiometabolic Disease, Diabetic Foot Ulcer (DFU), Epstein-Barr Virus Infection, HER2-negative Breast Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma
Studies at this site
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease — Recruiting now
- Study of CHS-114 in Participants With Advanced Solid Tumors — Recruiting now
- LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis — Recruiting now
- LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis — Recruiting now
- Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity — Recruiting now
- CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations — Recruiting now
- A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer — Recruiting now
- A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension — Completed
- A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101) — Running, not enrolling
- A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults — Running, not enrolling
- A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity — Running, not enrolling
- ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 — Completed
- Study of Obeldesivir in Nonhospitalized Participants With COVID-19 — Completed
- Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19 — Completed
- Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting — Stopped early
- Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma — Completed